HomeSUTLEJTEX › Filing
🔔 Get instant alerts when SUTLEJTEX files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 06 Aug 2026, 14:53 IST Exchange: NSE Category: Financial Results — Investor Presentation
AI summary - Q1FY27 standalone revenue 704 Cr +16.7% y-y; EBITDA 47 Cr (margin 6.7%, +585 bps y-y); PAT 3 Cr vs loss last year - Yarn segment: production 24,592 MT, sales 23,714 MT, EBIT 24 Cr; 87% capacity utilization - Home textiles revenue 48 Cr with near breakeven EBIT; 50% export mix and 466 active stores - EBITDA margin improved due to better product mix, cost control, and operational efficiencies - Strategic focus on value-added products, cost optimization, renewables, and geographic expansion - Executive Chairman highlights improved profitability and stronger balance sheet discipline - Sustainability initiatives include digital product passports and green fibre integration
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 SUTLEJTEX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SUTLEJTEX to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Sutlej Textiles and Industries Limited

Important. The summary above is generated automatically from Sutlej Textiles and Industries Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.